Balyasny Asset Management
PVLA

Balyasny Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Balyasny Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Sell
96,726
-12,154
-11% -$1.27M 0.02% 952
2025
Q4 		$11.4M Sell
108,880
-57,655
-35% -$4.92M 0.01% 964
2025
Q3 		$10.4M Buy
+166,535
New +$7.43M 0.01% 1032
2025
Q2 		– Sell
-8,176
Closed -$229K – 3481
2025
Q1 		$229K Buy
+8,176
New +$158K ﹤0.01% 2541
2022
Q1 		– Sell
-720
Closed -$218K – 2922
2021
Q4 		$218K Buy
+720
New +$231K ﹤0.01% 1822
2018
Q3 		– Sell
-210
Closed -$85K – 2099
2018
Q2 		$85K Buy
+210
New +$99.9K ﹤0.01% 1715
2017
Q4 		– Sell
-150
Closed -$69K – 2373
2017
Q3 		$69K Buy
+150
New +$64.1K ﹤0.01% 1801

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return